2017
DOI: 10.1016/j.ejphar.2017.07.011
|View full text |Cite
|
Sign up to set email alerts
|

Carbamazepine effects on pain management and serum IL-6, IL-10 evaluation in addicted patients undergoing surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 43 publications
0
6
0
Order By: Relevance
“…Perioperative pain may play an important role in modulating cytokines ( 25 ). For example, postoperative analgesic modalities after laparoscopic colorectal surgery attenuated the cytokine response as IL-6 expression ( 26 ).…”
Section: Discussionmentioning
confidence: 99%
“…Perioperative pain may play an important role in modulating cytokines ( 25 ). For example, postoperative analgesic modalities after laparoscopic colorectal surgery attenuated the cytokine response as IL-6 expression ( 26 ).…”
Section: Discussionmentioning
confidence: 99%
“…A randomised, double-blind experimental study conducted by Salimi et al sought to evaluate the use of pre-operative CBZ as a mitigating agent on post-operative analgesia in patients who had an addiction to opioids. 15 The primary outcome was to study the effect of pre-emptive CBZ use on pain behaviour, as well as to measure serum interleukin (IL) IL-6 and IL-10 levels. These inflammatory cytokines are routinely elevated in CBZ effectively decreased pain and modulated pain behaviour in patients with an addiction to opioids.…”
Section: Resultsmentioning
confidence: 99%
“…Though significant heterogeneity exists with regard to dosing regimens, patient populations, and markers of effectiveness, both CBZ and OXC are likely underutilised for this indication. 12,15 One method by which adjunctive analgesics are evaluated for their efficacy is the reduction in concomitant opioid doses. In a retrospective cohort analysis of 309 patients, Yang et al attempted to discover whether or not surgical intervention for trigeminal neuralgia led to less opioid usage.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Relevantly, many drugs routinely used for chronic pain management have been shown to decrease IL-6 levels, especially lidocaine IV, cannabinoids, and (indirectly) anticonvulsants. [17][18][19][20][21][22][23][24][25][26] According to the 2017 National Health Survey in Spain, [27] low back pain and osteoarthritis are the second and third most common health problems in Spain, affecting 18.5% and 17.5%, respectively, of the population. Given this high prevalence, the potential effects of drugs used to treat these and other comorbidities in patients with COVID-19 may be particularly relevant for individuals receiving medical treatment for chronic pain, which include NSAIDs, paracetamol, metamizole, corticosteroids, opioids, anticonvulsants, antidepressants, lidocaine, ketamine, cannabinoids, and naltrexone.…”
Section: Introductionmentioning
confidence: 99%